The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations

被引：23
|
作者：
Yang, Yi [1 ,2 ,3 ]
Ouyang, Jingzhong [4 ]
Zhou, Yanzhao [4 ]
Zhou, Jinxue [4 ]
Zhao, Hong [1 ,2 ,3 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Hepatobiliary Surg, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Gene Editing Screening & Res, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dev R&D Digest Syst Tumor Drugs, Beijing, Peoples R China
[4] Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 02期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.jhep.2022.03.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：574 / 576
页数：3
相关论文
共 50 条
  • [31] PREDICTORS OF IMMUNOTHERAPY (10) RESPONSE AND SUBSEQUENT TYROSINE KINASE INHIBITOR (TKI) RESPONSE IN HEPATOCELLULAR CARCINOMA (HCC).
    Armstrong, Samantha
    Kulasekaran, Monika
    Singh, Bhavana
    Prins, Petra
    He, Aiwu Ruth
    HEPATOLOGY, 2020, 72 : 702A - 703A
  • [32] Predictors of immunotherapy (IO) response and subsequent tyrosine kinase inhibitor (TKI) response in hepatocellular carcinoma (HCC).
    Armstrong, Samantha Ann
    Singh, Bhavana Pendurthi
    Kulasekaran, Monika
    Prins, Petra
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] BIOLOGICAL PREDICTIVE FACTORS IN ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH MULTITARGET TYROSINE KINASE INHIBITOR SORAFENIB
    Negri, F.
    Campanini, N.
    Dal Bello, B.
    Rossi, S.
    Tinelli, C.
    Bisagni, G.
    Porta, C.
    Salvagni, S.
    Ardizzoni, A.
    Silini, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 95 - 95
  • [34] Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor
    Ono, Takaaki
    Takahashi, Naoto
    Kizaki, Masahiro
    Kawaguchi, Tatsuya
    Suzuki, Ritsuro
    Yamamoto, Kazuhito
    Ohnishi, Kazunori
    Naoe, Tomoki
    Matsumura, Itaru
    CANCER SCIENCE, 2020, 111 (10) : 3714 - 3725
  • [35] Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors
    Uchikawa, Shinsuke
    Kawaoka, Tomokazu
    Ando, Yuwa
    Yamaoka, Kenji
    Kosaka, Yumi
    Suehiro, Yosuke
    Fujii, Yasutoshi
    Morio, Kei
    Nakahara, Takashi
    Murakami, Eisuke
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Takahashi, Shoichi
    Chayama, Kazuaki
    Aikata, Hiroshi
    ONCOLOGY, 2020, 98 (10) : 727 - 733
  • [36] The Glasgow Prognostic Score Is an Independent Prognostic Predictor of Hepatocellular Carcinoma Following Radical Resection
    Pan, Qun-Xiong
    Zhang, Jian-Hua
    Su, Zi-Jian
    Wang, Chong-Ren
    Ke, Shao-Ying
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (04) : 192 - 197
  • [37] A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Azemoto, Ryosaku
    Shinozaki, Masami
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    PLOS ONE, 2015, 10 (04):
  • [38] Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors
    Luo, Ning
    Li, Hu
    Luo, Yindeng
    Hu, Peng
    Liang, Luwen
    Zhang, Rong
    Zhang, Dazhi
    Cai, Dachuan
    Kang, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [39] Prognostic value of anthropometric features assessed by CT-scan in patients with advanced hepatocellular carcinoma treated by tyrosine kinase inhibitors
    Nault, Jean-Charles
    Pigneur, Frederic
    Costentin, Charlotte E.
    Tselikas, Lambros
    Luciani, Alain
    Laurent, Alexis
    Mallat, Ariane
    Duvoux, Christophe
    Rahmouni, Alain
    Decaens, Thomas
    HEPATOLOGY, 2013, 58 : 1262A - 1262A
  • [40] Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor
    Yukihiro, Kazuma
    Teishima, Jun
    Goto, Keisuke
    Aoki, Gaku
    Sekino, Yohei
    Hayashi, Tetsutaro
    Hasegawa, Yasuhisa
    Mita, Koji
    Kato, Masao
    Kajiwara, Mitsuru
    Shigeta, Masanobu
    Maruyama, Satoshi
    Kadonishi, Yuichi
    Fujiwara, Seiji
    Hinata, Nobuyuki
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (10) : 455.e11 - 455.e18
12345